Keith L Brownlie Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith L Brownlie.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith L Brownlie. Keith L Brownlie is Director in Celldex Therapeutics, Inc. ($AVAN) and Director in SOLIGENIX, INC. ($DOR) and Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and Director in RXi Pharmaceuticals Corp ($RXII).
Latest Insider Trading Transactions of Keith L Brownlie
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, IMNP, PHIO, SNGX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2020 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
| Jun 20 2019 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
| Feb 15 2019 | RXII | Phio Pharmaceutica ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Sep 28 2018 | SNGX | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jun 15 2018 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.32 | 8,000 | 18,560 | 8,000 | |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jun 12 2017 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
| Feb 12 2016 | RXII | RXi Pharmaceutical ... | Brownlie Keith L | Director | Option Exercise | A | 0.29 | 16,666 | 4,763 | 16,666 | |
| Jun 19 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
| Jun 02 2015 | RXII | RXi Pharmaceutical ... | Brownlie Keith L | Director | Option Exercise | A | 0.38 | 16,666 | 6,333 | 16,666 | |
| Apr 09 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | M | 0.61 | 14,286 | 8,714 | 0 | |
| Apr 09 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Buy | M | 0.61 | 14,286 | 8,714 | 50,000 | 35.7 K to 50 K (+40.00 %) |
| Aug 14 2013 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Grant | A | 0.00 | 300,000 | 0 | 360,000 | 60 K to 360 K (+500.00 %) |
| Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
| Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
| Apr 28 2011 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.67 | 55,000 | 36,850 | 55,000 |
Page: 1